Two new drugs to be licensed during this year

Published: 2002-06-25 07:00:00

Updated: 2002-06-25 07:00:00

This year will witness another market authorization of two new drugs developed by domestic pharmaceutical firms Gu-ju's antiarthritic agent Apitoxin inj. and LGCI's quinolone antibiotitc Factive, following the already licensed 4 new drugs; SK Chemical's Sunpla inj. Daewoong's EGF, Choong-wae's Q...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK